CordenPharma Expands GLP-1 Manufacturing Footprint in US and Europe with $980M Commitment

URLhttps://www.biospace.com/business/cordenpharma-exp
SourceBio Space
Date Published07/16/2024
Author NameTristan Manalac

Additional Reshoring Information:

Company/Division name CordenPharma
Type of work Manufacturing
Reshoring category:Foreign Direct Investment
Total number of jobs (added or to be added):200
Year reshoring announced:2024
Domestically, the work will be done:In-house
Capital investment ($):490
Country(ies) from which reshored:Germany,Switzerland
City reshored to:Boulder
State(s) reshored to:CO
If relevant, work nearshored to:-
Industry(ies):Chemicals
Product(s) reshoredpeptides for pharma
Find Reshoring Articles